Sektor Bicycle Therapeutics plc

Aktien

A2PKZC

US0887861088

BCYC

Biotechnologie

Markt geschlossen - 21:00:00 27.10.2026 Perf. 5 T Veränd. 1. Jan.
3.780 USD +3.56% Intraday Chart für Bicycle Therapeutics plc +6.93% -46.61%
Hauptkonkurrenten
% % 5 Tage Veränd. 1 Monat Veränd. 3 Monate % 1. Jan. Perf. 1 Jahr Perf. 3 Jahre Veränd. 5 Jahre Veränd. 10 Jahre Marktkap.($)
+3.56%+6.93%+2.58%-2.33%-46.61%-52.03%-75.21%-92.96% - 255 Mio.
-3.10%-3.43%-12.88%+13.18%+56.09%+36.29%+67.69%+1.93% - 65.28 Mrd.
+0.33%+7.26%-7.38%-2.69%+9.21%+11.51%+77.95%+218.47%+5’613.87% 54.57 Mrd.
+0.16%+3.69%+11.70%+16.02%+18.22%+8.39%+101.27%-15.72%+260.84% 53.59 Mrd.
-0.75%+2.13%+0.44%+30.52%+20.47%+23.14%+47.25%+6.04%+271.38% 45.03 Mrd.
-1.30%-1.11%+1.44%+12.32%+20.49%+17.77%+120.71%-4.58%+1’012.29% 42.17 Mrd.
+1.26%+2.23%-9.15%-1.59%+133.80%+241.81%+835.31%+586.40% - 39.42 Mrd.
-0.74%-4.84%+6.31%+6.19%+9.41%+14.53%+44.45%+3.10%+154.40% 32.71 Mrd.
-2.70%-7.34%-15.74%+14.22%+42.05%+23.17%+0.36%-62.78% - 24.01 Mrd.
+1.11%+17.90%+31.62%+59.54%+47.85%+56.87%+47.78%+1.77%+171.47% 26.5 Mrd.
+0.23%-2.41%-11.63%-2.54%-8.55%-17.60%-9.91%-70.22% - 21.82 Mrd.
+1.75%-0.35%-19.41%-11.19%-45.44%-40.52%+271.66%+253.54%+578.29% 20.38 Mrd.
-0.44%+8.74%+8.87%+12.04%+19.97%+11.33%+163.32%+216.30%+2’170.95% 18.93 Mrd.
+0.44%+19.61%+22.54%+58.37%+79.89%+82.12%+104.97%-16.52%+360.11% 17.06 Mrd.
-0.58%+8.28%+10.50%+28.73%+36.99%+35.86%+86.88%-16.65%+108.95% 16.69 Mrd.
+0.37%+4.26%+12.36%+18.02%+49.10%+68.78%+211.34%+201.71%+484.53% 16.13 Mrd.
+0.29%+6.91%+8.98%-3.16% - - - - - 16.1 Mrd.
+2.59%+1.28%+3.03%+4.85%+180.86%+162.43%+375.61%+1’411.75%+779.81% 14.75 Mrd.
-0.44%+8.83%+6.18%+10.39%+0.42%+2.73%-23.94%-35.83%+124.74% 14.18 Mrd.
-5.62%+0.27%-2.96%-11.83%+15.55%+3.56%+512.43% - - 14.63 Mrd.
Durchschnitt -0.18%+4.04%+2.37%+12.45%+33.67%+36.32%+155.79%+143.65%+930.12% 27.71 Mrd.
Nach Marktkapitalisierung gewichteter Durchschnitt -0.51%+2.92%+0.51%+13.05%+36.63%+40.69%+157.43%+121.79%+1’252.34%
  1. Börse
  2. Aktien
  3. A2PKZC Aktie
  4. Sektor Bicycle Therapeutics plc